Odyssey Health (ODYY) Operating Income Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Odyssey Health | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 22.09% |
| Oct 31, 2025 | 10.41% |
| Jul 31, 2025 | 33.04% |
| Apr 30, 2025 | 31.69% |
| Jan 31, 2025 | 20.71% |
| Oct 31, 2024 | 15.22% |
| Jul 31, 2024 | 14.99% |
| Apr 30, 2024 | -52.47% |
| Jan 31, 2024 | -66.76% |
| Oct 31, 2023 | -45.97% |
| Jul 31, 2023 | -51.61% |
| Apr 30, 2023 | -80.33% |
| Jan 31, 2023 | -45.02% |
| Oct 31, 2022 | -111.16% |
| Jul 31, 2022 | -102.99% |
| Apr 30, 2022 | -108.70% |
| Jan 31, 2022 | -137.72% |
| Oct 31, 2021 | -145.87% |
| Jul 31, 2021 | -142.60% |
| Apr 30, 2021 | -421.88% |
| Jan 31, 2021 | -112.18% |
| Oct 31, 2020 | -84.33% |
| Jul 31, 2020 | -117.16% |
| Apr 30, 2020 | -82.91% |
| Jan 31, 2020 | -58.81% |
| Oct 31, 2019 | -101.23% |